Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple reactive metabolites derived from bromobenzene.

S S Lau, T J Monks, J R Gillette

    Drug Metabolism and Disposition: the Biological Fate of Chemicals
    |May 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Redox stress and hepatic DNA fragmentation induced by diquat in vivo are not accompanied by increased 8-hydroxydeoxyguanosine contents.

    Redox report : communications in free radical research·2016
    Same author

    Arsenite and monomethylarsonous acid generate oxidative stress response in human bladder cell culture.

    Toxicology and applied pharmacology·2006
    Same author

    5-Aza-2'-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation.

    Oncogene·2006
    Same author

    Serotonergic neurotoxicity of methylenedioxyamphetamine and methylenedioxymetamphetamine.

    Advances in experimental medicine and biology·2002
    Same author

    Mutagenicity and carcinogenicity of biological reactive intermediate's derived from a "non-genotoxic" carcinogen.

    Advances in experimental medicine and biology·2002
    Same author

    Oxidative DNA damage and 8-hydroxy-2-deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer.

    Molecular carcinogenesis·2001
    Same journal

    Reduction of secondary 3-keto bile acids by aldo-keto reductase 1C1 and 1C4.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    Same journal

    High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    Same journal

    Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    Same journal

    Finding the dispersion number (D<sub>N</sub>) of the dispersion model from perfused rat and human liver studies.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    Same journal

    Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    Same journal

    The regulatory potential of cytochrome P450-adrenodoxin interactions: Insights toward understanding redox partner regulation in drug metabolizing enzymes.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    See all related articles

    Bromobenzene and p-bromophenol are metabolized by cytochromes P-450 into reactive intermediates. These metabolites bind to proteins but do not cause toxicity in vivo, suggesting a non-toxic pathway.

    Area of Science:

    • Biochemistry
    • Toxicology
    • Drug Metabolism

    Background:

    • Bromobenzene metabolism generates reactive intermediates.
    • The precise nature of these reactive metabolites remains poorly understood.
    • Understanding these pathways is crucial for assessing potential toxicity.

    Purpose of the Study:

    • To elucidate the reactive metabolites of bromobenzene and p-bromophenol.
    • To investigate the enzymes involved in their activation.
    • To determine the toxicological significance of these metabolites.

    Main Methods:

    • Utilized rat liver microsomes for in vitro metabolism studies.
    • Employed competitive inhibition assays with bromobenzene and p-bromophenol.
    • Investigated the role of various enzymes (epoxide hydrolase, COMT, SOD, catalase) and antioxidants (glutathione, ascorbic acid) in metabolite binding.

    Related Experiment Videos

    Main Results:

    • Cytochromes P-450 activate both bromobenzene and p-bromophenol, with competitive inhibition observed.
    • Covalent binding of p-bromophenol metabolites was inhibited by epoxide hydrolase, COMT, SOD, glutathione, and ascorbic acid.
    • Formation of 4-bromocatechol from p-bromophenol was influenced by glutathione, ascorbic acid, and SOD.
    • Reactive metabolites, likely an epoxide and a quinone, are formed but appear non-toxic in vivo.

    Conclusions:

    • p-Bromophenol is metabolized to an epoxide, which can decompose to 4-bromocatechol.
    • Both the epoxide and a quinone derived from 4-bromocatechol can bind covalently to proteins.
    • Despite covalent binding, these reactive metabolites of p-bromophenol are likely non-toxic in vivo.